A toolkit to address disparities in digitally enabled oncology trials By Ogkologos - September 5, 2025 672 0 Facebook Twitter Google+ Pinterest WhatsApp An initiative fosters inclusive research by improving patient access and participation in cancer research Source RELATED ARTICLESMORE FROM AUTHOR ESMO Strengthens Global Oncology Collaboration Through its Growing Presence in the Asia-Pacific Pemigatinib Prolongs mPFS Over Chemotherapy in Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements FDA Approves Atezolizumab for Adjuvant Treatment of Muscle Invasive Bladder Cancer in Patients with Molecular Residual Disease MOST POPULAR Ahead of ESMO Immuno-Oncology Congress 2025: topics at a glance December 4, 2025 Adding Gedatolisib to Fulvestrant, with or without Palbociclib, Improves PFS in... March 17, 2026 Survival Benefit of Enfortumab Vedotin and Pembrolizumab Compared with Chemotherapy in... March 11, 2024 Mother and Son with Shared BRCA Gene Mutation Go Through Cancer... September 23, 2020 Load more HOT NEWS Dad Is Making Baby Giggle, But When He Makes A Sheep... Intracranial Efficacy of Pembrolizumab in Patients with Brain Metastases ctDNA Sequencing Reliably Detects KIT/PDGFRA Mutations and Correlates with Outcomes in... FDA Grants Accelerated Approval to Sevabertinib for Non-Squamous NSCLC
